LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,519
تعداد مشاهده مقاله45,424,599
تعداد دریافت فایل اصل مقاله11,296,689
Xu, Weidong, Chen, Zheng, Shen, Xiaodong, Pi, Chiheng. (1398). Reno-Protective Effect of Realgar Nanoparticles on Lupus Nephritis of MRL/Lpr Mice through STAT1. سامانه مدیریت نشریات علمی, 16(2), 170-181. doi: 10.22034/iji.2019.80260
Weidong Xu; Zheng Chen; Xiaodong Shen; Chiheng Pi. "Reno-Protective Effect of Realgar Nanoparticles on Lupus Nephritis of MRL/Lpr Mice through STAT1". سامانه مدیریت نشریات علمی, 16, 2, 1398, 170-181. doi: 10.22034/iji.2019.80260
Xu, Weidong, Chen, Zheng, Shen, Xiaodong, Pi, Chiheng. (1398). 'Reno-Protective Effect of Realgar Nanoparticles on Lupus Nephritis of MRL/Lpr Mice through STAT1', سامانه مدیریت نشریات علمی, 16(2), pp. 170-181. doi: 10.22034/iji.2019.80260
Xu, Weidong, Chen, Zheng, Shen, Xiaodong, Pi, Chiheng. Reno-Protective Effect of Realgar Nanoparticles on Lupus Nephritis of MRL/Lpr Mice through STAT1. سامانه مدیریت نشریات علمی, 1398; 16(2): 170-181. doi: 10.22034/iji.2019.80260

Reno-Protective Effect of Realgar Nanoparticles on Lupus Nephritis of MRL/Lpr Mice through STAT1

Iranian Journal of Immunology
مقاله 8، دوره 16، شماره 2، شهریور 2019، صفحه 170-181    اصل مقاله (1 M)
نوع مقاله: Original Article
شناسه دیجیتال (DOI): 10.22034/iji.2019.80260
نویسندگان
Weidong Xu* 1؛ Zheng Chen1؛ Xiaodong Shen1؛ Chiheng Pi2
1Department of Rheumatology, The Affiliated Hospital of University of Jiangxi TCM, Jiangxi, China
2Famous Chinese Traditional Medicine Center, The Affiliated Hospital of University of Jiangxi TCM, Jiangxi, China
چکیده
Background: Realgar, an arsenic tetrasulfide compound, is a highly recognized traditional Chinese medicinal prescription that has been widely used to treat various diseases such as inflammatory diseases. However, there are still some problems in the clinical treatment of Realgar, such as large oral dose and high potential toxicity. Objective: To evaluate effects of Realgar nanoparticles on lupus nephritis (LN) in vivo in MRL/lpr mice. Methods: Ten-week mice were orally administered every day for eight consecutive weeks except the mice of normal model groups. The serum levels of anti-ds-DNA antibody IgG, IgM, IFN-γ, Creatinine (Cr), and blood urea nitrogen (BUN) were determined, and 24-hour urine protein was also measured. Renal inflammatory pathology analysis was assessed by hematoxylin-eosin (H&E) staining. The expression of phosphorylated signal transducer and activator of transcription 1 (p-STAT 1) and Janus Kinase 1 (JAK 1) in kidney tissue was determined by direct reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry (IHC). Results: The mice treated with Realgar nanoparticle in the high dose-treated (Realgar HD, 0.03 g/kg/d) group exhibited significantly reduced serum levels of anti-dsDNA (p<0.01), IgG (p<0.01), IgM (p<0.01), BUN (p<0.01), Cr (p<0.01), and inflammatory cytokine IFN-γ (p<0.01) as well as proteinuria (p<0.01) compared to the untreated model MRL/lpr mice. Additionally, high doses of Realgar nanoparticles significantly suppressed the phosphorylations of STAT 1 (p<0.01) and the renal pathological changes. Conclusions: The study indicates that Realgar nanoparticles may be a potential agent to treat LN, and the down-regulated p-STAT1 expression suggests that it may be one of the LN treatment targets for Realgar nanoparticles.
کلیدواژه‌ها
JAK1/STAT1 Signaling Pathway؛ Lupus Nephritis؛ MRL/lpr Mice؛ p-STAT 1؛ Realgar Nanoparticle
آمار
تعداد مشاهده مقاله: 2,065
تعداد دریافت فایل اصل مقاله: 1,534


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب